12:00 PM EST - Nuvo Pharmaceuticals Inc. : Announced that the United States District Court for the District of New Jersey has denied a motion for summary judgment filed by Dr. Reddy's Laboratories Inc. (DRL). As a result, the patent infringement litigation against DRL, involving Nuvo Pharmaceuticals (Ireland) DAC's (Nuvo Ireland) U.S. Patent Nos. 8,858,996 and 9,161,920 (the '996 and '920 patents), will continue. Nuvo Pharmaceuticals Inc.
shares T.NRI are trading up $0.05 at $0.44.
